Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.6K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.6K
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

3.6K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
3.6K
Menopause01:28

Menopause

5.2K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.2K
Signs of Puberty01:27

Signs of Puberty

2.1K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
2.1K
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

3.6K
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
3.6K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

4.2K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of androgen receptor polymorphism on hypogonadism severity and efficacy of testosterone replacement therapy.

Translational andrology and urology·2026
Same author

Impact of testosterone therapy and hypogonadism on treatment outcomes in Peyronie's disease: a multicenter retrospective analysis of collagenase clostridium histolyticum therapy.

The journal of sexual medicine·2026
Same author

Clinical outcomes in Peyronie's disease: impact of curvature severity and disease phase on symptom resolution and treatment response.

The journal of sexual medicine·2026
Same author

Sexual Health.

The Journal of urology·2026
Same author

Efficacy and safety of collagenase <i>Clostridium histolyticum</i> in men who have sex with men.

Sexual medicine·2026
Same author

The interplay between testosterone and depression: bridging research, clinical applications, and health: a narrative review.

Sexual medicine reviews·2026

Related Experiment Video

Updated: Apr 20, 2026

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

48.3K

Testosterone replacement in normal and pathologic prostate.

Mohit Khera

    Hormone Molecular Biology and Clinical Investigation
    |December 2, 2014
    PubMed
    Summary

    Testosterone replacement therapy (TRT) is rapidly growing due to reduced concerns about prostate cancer and benign prostatic hyperplasia (BPH). Studies suggest TRT may even improve BPH symptoms, aiding safe treatment for hypogonadism.

    Area of Science:

    • Endocrinology
    • Urology
    • Pharmacology

    Background:

    • The testosterone replacement therapy (TRT) market has seen significant growth.
    • Exogenous testosterone is a rapidly expanding prescription medication in the USA.
    • Spending on testosterone increased 115.5% and prescriptions rose 64.5% from 2005-2009.

    Purpose of the Study:

    • To investigate the reasons behind the rapid growth in the TRT market.
    • To address lingering concerns regarding TRT's impact on prostate health.
    • To explore the safety of TRT in men with hypogonadism and prostatic conditions.

    Main Methods:

    • Review of market trends and prescription data for TRT.
    • Analysis of recent studies on TRT and prostate cancer risk.

    More Related Videos

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    14.1K
    Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
    08:38

    Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

    Published on: August 28, 2013

    26.4K

    Related Experiment Videos

    Last Updated: Apr 20, 2026

    Murine Prostate Micro-dissection and Surgical Castration
    08:49

    Murine Prostate Micro-dissection and Surgical Castration

    Published on: May 11, 2016

    48.3K
    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    14.1K
    Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
    08:38

    Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

    Published on: August 28, 2013

    26.4K
  • Examination of research on TRT effects on benign prostatic hyperplasia (BPH) symptoms.

    • Main Results:

    • Decreased concerns about TRT causing prostate cancer have fueled market growth.
    • Reduced apprehension regarding TRT worsening BPH symptoms.
    • Emerging evidence suggests TRT may improve BPH symptoms.

    Conclusions:

    • The TRT market expansion is driven by evolving perceptions of its safety profile.
    • The prostate saturation theory offers a framework for understanding safe TRT administration.
    • TRT can be safely administered to men with hypogonadism, even with existing prostate disease.